OTC/Supplement Combinations "Serious Concern" For FDA
This article was originally published in The Tan Sheet
Executive Summary
The appropriateness of combination products containing OTC drug and dietary supplement ingredients is under review at FDA. In the interim, the agency is discouraging firms from marketing such items.